Vecura
定价解决方案
资源
Vecura

产品

  • 解决方案
  • 定价

公司

  • 联系我们
  • 学术研究计划

资源

  • 更新
  • 新闻
  • 洞察
  • 使用案例
  • AI4Life Bootcamp
  • 社区

法律条款

  • 隐私政策
  • 服务条款
  • 引用指南
  • 信任中心

© 2026 NYB AI 保留所有权利。

所有系统运行正常
Vecura
定价解决方案
资源
返回更新

ProGen2 Is Now Available on Vecura — Design and Score Proteins Without the Infrastructure Overhead

This update enables biotech researchers and protein engineers to generate novel protein sequences and evaluate their fitness through a guided workflow inside Vecura, without setting up complex GPU infrastructure or managing large-scale language model deployments.

Oct 5, 2026ProGen2
ProGen2
ProGen2 is now available on Vecura

What is ProGen2?

ProGen2 is a suite of autoregressive transformer-based protein language models developed by Salesforce Research, ranging from 151 million to 6.4 billion parameters. Trained on diverse protein sequence databases — including UniRef90, BFD30, BFD90, and the Observed Antibody Space (OAS) — the models treat amino acid sequences as token streams to enable both de novo sequence generation and likelihood-based scoring. A specialist variant, progen2-oas, is fine-tuned exclusively on antibody repertoires, making it particularly well-suited for antibody engineering tasks.

It helps users design novel protein candidates from scratch, continue partial sequences, and rank variants using zero-shot bidirectional log-likelihood scoring — all without labelled training data or structural inputs. It is especially useful for early-stage protein engineering, antibody design, and computational screening pipelines that need to prioritize candidates before committing to wet-lab synthesis.

What can users do with ProGen2 on Vecura?

With ProGen2 on Vecura, users can:

  • Generate novel protein sequences from scratch or from a context-seeded prefix using configurable nucleus sampling, controlling the trade-off between sequence diversity and similarity to natural proteins.
  • Score and rank candidate sequences using bidirectional log-likelihood as a zero-shot fitness proxy — no labelled data, alignments, or structural information required.
  • Design antibody sequences using the progen2-oas specialist variant trained on the Observed Antibody Space repertoire.
  • Fine-tune generation parameters — temperature, top-p, sequence length, and number of samples — to explore sequence space systematically and balance novelty against naturalness.

What the output means

The output provides:

  • Generated sequences: Novel amino acid strings produced by the model, ready to be passed to structure predictors or wet-lab screening pipelines.
  • Bidirectional log-likelihood scores: Including sum and mean values for left-to-right, right-to-left, and averaged directions. Units are nats (sum) or nats per residue (mean). Higher (less negative) values indicate sequences that are more probable under the model and more consistent with natural protein distributions, serving as a calibrated proxy for functional fitness.

This output should be used to support scientific decision making. It does not replace experimental validation.

Why this matters

Protein engineering has traditionally relied on costly and time-consuming experimental screening to identify functional variants from vast sequence spaces. Language models like ProGen2 offer a powerful computational shortcut: by learning the statistical grammar of natural proteins from over a billion sequences drawn from genomic, metagenomic, and immune repertoire databases, these models can propose plausible candidates and flag unlikely ones before any physical experiment takes place. The ProGen2 research demonstrated that scaling autoregressive modelling into the multi-billion parameter regime yields measurably lower perplexity and higher experimental hit rates — a finding that underscores the importance of model scale in protein design.

The availability of ProGen2 on Vecura lowers the barrier to entry for research teams that lack dedicated ML infrastructure or access to high-VRAM GPU clusters (the 6.4B parameter model alone requires ~40 GB of VRAM). Scientists can now access state-of-the-art protein language models through a simple, guided interface, accelerating the design-build-test cycle and enabling rapid iteration on therapeutic proteins, industrial enzymes, and antibody candidates.


  • Developed by: Salesforce Research
  • Source: ProGen2 GitHub Repository · Pretrained Checkpoints
  • Reference: Nijkamp, E., Ruffolo, J.A., Weinstein, E.L., Madani, N., & Bandyopadhyay, A. (2023). ProGen2: Exploring the boundaries of protein language models. Cell Systems. arXiv:2206.13517

在 Vecura 上试用 ProGen2

打开模型工作区,用您自己的输入开始评估

试用模型

主题

protein-generationprotein-language-modelfitness-scoringautoregressivezero-shot

On this page

What is ProGen2?What can users do with ProGen2 on Vecura?What the output meansWhy this matters

在 Vecura 上试用 ProGen2

试用模型

相关文章

ESM-Scan is now available on Vecura

Predict Protein Mutational Effects with ESM-Scan on Vecura

May 12, 2026

Profluent-E1 is now available on Vecura

Protein Analysis at Scale: Profluent-E1 is Now Integrated into Vecura

May 12, 2026

AbLang2 is now available on Vecura

Unlock Advanced Antibody Analysis with AbLang2 on Vecura

Sep 22, 2026

Vecura

产品

  • 解决方案
  • 定价

公司

  • 联系我们
  • 学术研究计划

资源

  • 更新
  • 新闻
  • 洞察
  • 使用案例
  • AI4Life Bootcamp
  • 社区

法律条款

  • 隐私政策
  • 服务条款
  • 引用指南
  • 信任中心

© 2026 NYB AI 保留所有权利。

所有系统运行正常